So-Young International (SY) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
25 Mar, 2026Executive summary
Achieved record Q4 revenue of RMB 461 million, up 25% year-over-year, driven by rapid expansion and operational improvements in the branded aesthetic center business.
Aesthetic center business became the largest revenue segment, with 49 centers opened by year-end and verified treatment visits up 178% year-over-year.
Net loss attributable to shareholders narrowed significantly to RMB 108.8 million in Q4 2025 from RMB 607.6 million a year ago.
Core member quarterly repurchase rate exceeded 80%, with average annual spending of RMB 16,500, reflecting strong user loyalty and trust.
For FY2025, revenues increased 3.9% to RMB 1,523.4 million, with net loss reduced to RMB 242.3 million from RMB 589.5 million in FY2024.
Financial highlights
Q4 total revenue reached RMB 460.7 million, up 24.8% year-over-year.
Revenues from aesthetic treatment services were RMB 248.1 million, up 205.3% year-over-year, surpassing 50% of total revenue for the first time.
Net loss attributable to shareholders was RMB 108.8 million, a significant improvement from RMB 607.6 million in Q4 2024.
Non-GAAP net loss was RMB 93.4 million, compared to RMB 53.2 million in Q4 2024.
Cash and equivalents stood at RMB 936.4 million at year-end, down from RMB 1,253.2 million a year earlier, mainly due to investment in new centers.
Outlook and guidance
Q1 2026 aesthetic treatment services revenue expected between RMB 268–278 million, representing 171.2%-181.3% year-over-year growth.
At least 35 new centers planned for 2026, with a strategic shift to balance scale and profitability.
Management plans steady store expansion, operational excellence, and strategic alliances to drive sustainable value.
Focus on improving gross margins through operational efficiency, cost optimization, and mature center contribution.
Latest events from So-Young International
- Goodwill impairment drove a net loss, but aesthetic center revenue grew over 700% year-over-year.SY
Q4 202417 Mar 2026 - Branded centers drove a 551% surge in treatment services revenue amid overall revenue decline.SY
Q1 202517 Mar 2026 - Aesthetic treatment services revenue soared 426% YoY, now the largest segment, with 50 centers targeted by year-end.SY
Q2 202517 Mar 2026 - Q2 revenue exceeded guidance, profit improved, but Q3 revenue is expected to decline.SY
Q2 202423 Jan 2026 - Q3 revenue exceeded guidance, with strong clinic and medical product growth and higher profitability.SY
Q3 202413 Jan 2026 - Aesthetic treatment revenues jumped 305% YoY, but higher costs led to a net loss.SY
Q3 202517 Nov 2025